Pa Tho Physiology of Lymphomas

download Pa Tho Physiology of Lymphomas

of 17

Transcript of Pa Tho Physiology of Lymphomas

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    1/17

    PATHOPHYSIOLOGY OF LYMPHOMAS

    Rick Allen

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    2/17

    LYMPHOMA

    Leukaemia involves widespread bonemarrow involvement and a presence inperipheral blood.

    Lymphomas arise in discrete tissue masses

    (commonly lymph nodes), with potentiallyonly minor peripheral blood presence.

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    3/17

    CLASSIFICATION BASED ON CELL ORIGIN

    Precursor B cell neoplasms(premature B)

    Peripheral B cell neoplasms(mature B)

    Precursor T cell neoplasm(premature T)

    Peripheral T cell and NK cell

    neoplasm (mature T and NK) Hodgkin (Reed-Sternberg cells

    and variants)

    Non

    HodgkinsLymphoma(NHL)

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    4/17

    ROBBINS P 599

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    5/17

    NHL PREM B AND T

    ALL

    That is all

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    6/17

    NHL PERIPHERAL B CELL NEOPLASM

    CLL/Small Lymphocytic Lymphoma

    Tissue manifestation of CLL. Psuedofollicular.

    Immunophenotype:CD 19/20/23/5

    Aetiology:deletion of 13q (TSG), 14q, 17p andtrisomy 12q

    Pathophysiolology:Growth confined to

    proliferation centres. Microenvironmentstimulates NF-B. Immune function buggered byunknown mechanism

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    7/17

    NHL PERIPHERAL B CELL NEOPLASM

    Follicular Lymphoma

    Most common form of indolentNHL

    Immunophenotype:CD19/20/10, Ig, BCL 2 and

    6

    Aetiology:Germinal centre B cells, t(14:18)[BCL2]

    Pathophysiolology:BCL2 antagonisesapoptosis and promotes survival. Calls inreactive cells. Marrow, spleen and liverinvolvement common. Goes where B cells go

    (white pulp)

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    8/17

    NHL PERIPHERAL B CELL NEOPLASM

    Diffuse Large B-cell Lymphoma

    Most common NHL. Diffuse growth, massivecells

    Immunophenotype:CD19/20, Ig, BCL 6

    Aetiology:BCL6 overexpression mutation:represses germinal B cell differentiation and

    growth arrest, silences p53Pathophysiolology:rapidly enlarging mass.

    Waldeyer ring is common. Destructive mass inliver or spleen (1 or 2). Aggressive, commonly

    fatal

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    9/17

    NHL PERIPHERAL B CELL NEOPLASM

    Burkitt Lymphoma

    Mature B cells. Starry sky pattern. Diffuse.

    Immunophenotype:CD19/20/10, IgM, BCL6

    Aetiology:t(8,2/14/22), c-MYC gene with apromoter expression. p53 point mutation.EBV involvement

    Pathophysiolology:extranodal sights in kidsand young adults. Jaw and abdo viscera.

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    10/17

    NHL PERIPHERAL B CELL NEOPLASM

    Mantle cell Lymphoma

    Resemble mantle B cells (surround germinalcentre). Nodular or diffuse

    Immunophenotype: cyclin D1, CD19/20/5, Ig.

    Aetiology:t(11;14) cyclin D1 upregulation G1-S phase progression

    Pathophysiolology:Painless lymphadenopathy.Spleen and gut involvement symptoms.

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    11/17

    NHL PERIPHERAL B CELL NEOPLASM

    Marginal zone Lymphoma

    Extranodal sites and MALTs

    Arise:

    Chronic inflammation due to autoimmunity or infection(thyroid Hashimoto, stomach Heliobacter)

    Localised for a fair period

    May regress if stimulant is removed.

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    12/17

    PERIPHERAL T CELL LYMPHOMA

    Immunophenotype:CD2/3/5

    Types Anaplastic Large-cell Lymphoma (rare)

    Mycosis Fungoides/Sezary syndromeCD4 Th cells go to the skin, invading the upper dermisand epidermis. 3 distinct phases. Uses adhesionmolecule.

    Adult T cell

    Infected with Human T cell leukaemia retrovirus type 1(HTLV-1), NF-B. Bad prognosis.

    Large Granular Lymphoblastic Lymphoma (rare) Extranodal NK/T cell Lymphoma

    Surrounds and invades small vessels ischaemic

    necrosis. EBV involved

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    13/17

    HODGKINS LYMPHOMA

    Classical HLNodular sclerosis

    Mixed cellularity

    Lymphocyte rich (rare) Lymphocyte depletion (rare)

    Lymphocyte pre-dominance (rare)

    Difference? Immunophenotypes of Reed-Sternberg (RS) Cells.

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    14/17

    HODGKINS LYMPHOMA

    Aetiology:B-cells are from germinal/post-germinal

    centre

    A mechanism (commonly EBV infection viaLMP-1) NF-B inhibitor mutation act.Transcription factor NF-B act. Lymphocyteproliferation and survival genes

    Theory: saves defective B cell from apoptosis,mutates to RS cell

    RS secretes cytokines (IL-5,10,13, TNF-)and chemokines calling reactive cells

    (majority) release factors to promote

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    15/17

    ROBBINS P621

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    16/17

    HODGKINS LYMPHOMA

    Pathophysiology:

    Node spleen liver marrow/other tissues

    Suppressed Th1 immune response.

    Mediastinal involvement breathing issues.

    Generally slower progression

  • 8/2/2019 Pa Tho Physiology of Lymphomas

    17/17

    HL VS. NHL

    HL NHL

    more often localized to a single

    axial group of nodes (cervical,mediastinal, para-aortic)

    More frequent involvement of

    multiple peripheral nodes.

    Orderly spread by contiguity Noncontiguous spread

    Mesenteric nodes and Waldeyer

    ring rarely involved

    Waldeyer ring and mesenteric

    nodes commonly involved

    Extra-nodal presentation rare. Extra-nodal presentation

    common